Clinical Decision Support

AF Expert

Atrial Fibrillation Management · NICE NG196 · AI-powered cardiology advisor

11
Guideline Sections
47+
Recommendations
5
Anticoagulants Covered
2
Risk Tools
AI

AF Expert Advisor

NICE NG196 · Powered by Claude

Ready

Ask a clinical question or choose a scenario:

For clinical decision support only. Always apply clinical judgement.

Quick Reference

CHA₂DS₂-VASc ≥2Offer DOAC (Rec 1.6.3)
CHA₂DS₂-VASc 1 (M)Consider DOAC (Rec 1.6.4)
TTR <65%Reassess anticoagulation (Rec 1.6.11)
Onset <48hRate or rhythm control (Rec 1.8.2)
Onset >48hRate control + 3wk OAC pre-DCCV
HF + AFNo CCBs (Rec 1.7.3 & 1.8.3)
Structural HD + rhythm RxAmiodarone only (Rec 1.7.13)
Post-ablationAntiarrhythmic 3 months (Rec 1.7.22)

DOAC Options (Rec 1.6.9)

ApixabanTA275
DabigatranTA249
EdoxabanTA355
RivaroxabanTA256

Use in line with individual NICE TA criteria. Check renal function and dose adjustments.

⚠ Key Prohibitions

  • ✗ Aspirin monotherapy for stroke prevention
  • ✗ Amiodarone for long-term rate control
  • ✗ Class 1c drugs in ischaemic/structural HD
  • ✗ CCBs in HFrEF or decompensated HF
  • ✗ Stop OAC solely because AF no longer detected
  • ✗ LAAO as alternative to OAC if OAC tolerated
  • ✗ Routine TTE solely for stroke risk if OAC agreed
  • ✗ Statins started de novo to prevent post-op AF